Form 8-K - Current report:
SEC Accession No. 0000950170-25-002828
Filing Date
2025-01-07
Accepted
2025-01-07 16:05:18
Documents
13
Period of Report
2025-01-03
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K revb-20250103.htm   iXBRL 8-K 48137
2 EX-99.1 revb-ex99_1.htm EX-99.1 19898
3 GRAPHIC img220778470_0.jpg GRAPHIC 18521
  Complete submission text file 0000950170-25-002828.txt   249768

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT revb-20250103.xsd EX-101.SCH 47719
15 EXTRACTED XBRL INSTANCE DOCUMENT revb-20250103_htm.xml XML 6765
Mailing Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122
Business Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 650-800-3717
REVELATION BIOSCIENCES, INC. (Filer) CIK: 0001810560 (see all company filings)

EIN.: 843898466 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39603 | Film No.: 25514885
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)